New research published 2 May 2017 in the European Respiratory Journal by trainee Lorena Vehling and CHILD investigator Dr. Meghan Azad shows that breastfed babies have a reduced rate of wheezing, putting them at a lower risk for asthma later on.
The study also finds that among “high-risk” infants born to mothers with asthma, breastfeeding is especially protective against wheezing.
The study, “Breastfeeding, maternal asthma, and wheezing in the first year of life: a longitudinal birth cohort study,” analyzes data from 2,700 infants and their parents participating in the CHILD Study.
2 May 2017
A study of over 2,700 Canadian mothers and infants has shown that babies who are breastfed longer are less likely to wheeze, putting them at lower risk for asthma later on. For babies born to mothers with asthma, the protective effect of breastfeeding is even more pronounced.
Wheezing (a whistling sound in the chest) is one of the most common reasons why infants are hospitalized or need medical care, and is associated with a higher risk of childhood asthma.
The study, published today in the European Respiratory Journal, found that at three months of age, infants who were exclusively breastfed had a 26% reduced rate of wheezing compared to infants who were not breastfed. Breastfeeding was similarly protective at six months of age, and at one year, infants who were still being breastfed had a 33% reduced rate of wheezing compared to those who breastfed for less than six months.
“For babies who are at high risk for developing asthma because their mothers have the condition, breastfeeding was especially beneficial,” says lead author Dr. Meghan Azad, an assistant professor in the Rady Faculty of Health Sciences at the University of Manitoba and a research scientist at the Children’s Hospital Research Institute of Manitoba (CHRIM). “Among these high-risk babies, those who were exclusively breastfed for six months had a 62% reduced rate of wheezing compared to those who were not breastfed—which is very significant.”
Dr. Azad is an AllerGen investigator working with the Canadian Healthy Infant Longitudinal Development (CHILD) Study—a national birth cohort study collecting a wide range of health, lifestyle and environmental exposure information from more than 3,500 mothers and children from pregnancy to school age—with the local study site hosted within CHRIM. As part of the CHILD Study, parents completed detailed questionnaires about the duration and exclusivity of breastfeeding, as well as their child’s health and development, including a description of wheezing episodes throughout the first year of life.
The study’s findings strengthen existing evidence about the benefits of breastfeeding, identify new maternal and infant factors associated with breastfeeding and wheezing, and contribute new evidence regarding the introduction of complementary foods. Currently, the World Health Organization (WHO) recommends exclusive breastfeeding for six months to achieve optimal infant growth and development, yet there is emerging evidence that earlier introduction of certain complementary foods may reduce the risk of allergic disease.
“We found that the benefits of exclusive breastfeeding were diminished by supplementation with infant formula before six months of age, but not by the introduction of complementary foods,” says Dr. Azad. “This was an interesting result that may help to inform infant feeding guidelines and guide further research on the bioactive properties of human milk.”
The research also showed that infants were less likely to be breastfed if their mothers were younger, smoked, or had not finished post-secondary education, suggesting that these mothers and their children could especially benefit from programs to support breastfeeding.
“Given the substantial health and economic burden imposed by infant wheezing and the potential for these children to develop asthma down the road, our results support the endorsement of breastfeeding as a cost-effective strategy to prevent infant wheezing and promote lifelong respiratory health,” says Dr. Azad.
This research was funded by the Heart and Stroke Foundation and Canadian Lung Association Emerging Research Leaders Initiative, in partnership with the Canadian Respiratory Research Network and the Allergy, Genes and Environment Network of Centres of Excellence (AllerGen NCE). The CHILD Study is supported by the Canadian Institutes of Health Research and AllerGen NCE.
Read the ResearchSKETCH lay summary for this research.